KanonCure Inc.
PrivateLast Round
VC Round
Aug 5, 2021
Company Overview
KanonCure Inc. is a biotechnology company that develops regenerative medical products and drugs for the treatment of liver diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
KanonCure Inc. Comparables
Compare KanonCure Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Senno Therapeutics Inc. | 79% | |
| Resolution Therapeutics | 76% | |
| Rohto Pharmaceutical | 70% | |
KanonCure Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Aug 5, 2021 | ||||
| VC Round | Sep 27, 2018 | ||||
| VC Round | Jul 25, 2018 |
KanonCure Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| JR West Innovations Co., Ltd. | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2018
Funding round included JR West Innovations Co., Ltd.
KanonCure Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about KanonCure Inc.'s valuation, stock price, and market status.